BPI Theater @ BIO 2014

Featured on BPI Theater @ BIO 2014

Benefits of Using a CMO for Antibody Drug Conjugates logo in a gray background |
Manufacturing
Benefits of Using a CMO for Antibody Drug ConjugatesBenefits of Using a CMO for Antibody Drug Conjugates

byCynthia Wooge
Sep 12, 2014
The Future Directions of ADC Development logo in a gray background |
Manufacturing
The Future Directions of ADC DevelopmentThe Future Directions of ADC Development
byDavid Rabuka
Sep 12, 2014
An Integrated Approach to Cell Line and Process Development of Therapeutic Antibodies: A Case Study in Development of a Biosimilar logo in a gray background |
Manufacturing
An Integrated Approach to Cell Line and Process Development of Therapeutic Antibodies: A Case Study in Development of a BiosimilarAn Integrated Approach to Cell Line and Process Development of Therapeutic Antibodies: A Case Study in Development of a Biosimilar
byBPI Staff
Sep 12, 2014
The Importance of Media Selection and Scale-Down Models for High-Titer Expression in CHO Cells logo in a gray background |
Manufacturing
The Importance of Media Selection and Scale-Down Models for High-Titer Expression in CHO CellsThe Importance of Media Selection and Scale-Down Models for High-Titer Expression in CHO Cells
byBPI Staff
Sep 12, 2014
Genome Engineering and SURECHO-Mplus Libraries for Optimal Transgene Expression and Recombinant Protein Production logo in a gray background |
Manufacturing
Genome Engineering and SURECHO-Mplus Libraries for Optimal Transgene Expression and Recombinant Protein ProductionGenome Engineering and SURECHO-Mplus Libraries for Optimal Transgene Expression and Recombinant Protein Production
byBPI Staff
Sep 12, 2014
Navigating the Biosimilars Landscape: Dispelling the Myths logo in a gray background |
Manufacturing
Navigating the Biosimilars Landscape: Dispelling the MythsNavigating the Biosimilars Landscape: Dispelling the Myths
byBPI Staff
Sep 12, 2014

More from BPI Theater @ BIO 2014

Masking and Demasking of Endotoxin (LPS) in Biopharmaceutical Formulations logo in a gray background | Masking and Demasking of Endotoxin (LPS) in Biopharmaceutical Formulations
Manufacturing
Masking and Demasking of Endotoxin (LPS) in Biopharmaceutical Formulations
Masking and Demasking of Endotoxin (LPS) in Biopharmaceutical Formulations
Sep 12, 2014
byBPI Staff
Integrating Technologies to Seamlessly Transition Cell Therapy Products from Clinical Research to Commercial-Scale Manufacturing logo in a gray background | Integrating Technologies to Seamlessly Transition Cell Therapy Products from Clinical Research to Commercial-Scale Manufacturing
Manufacturing
Integrating Technologies to Seamlessly Transition Cell Therapy Products from Clinical Research to Commercial-Scale Manufacturing
Integrating Technologies to Seamlessly Transition Cell Therapy Products from Clinical Research to Commercial-Scale Manufacturing
Sep 12, 2014
byBPI Staff
Best Practices in Supply Chain Logistics: How Blood Centers Participate in Collection, Storage, and Delivery of Cell Therapies logo in a gray background | Best Practices in Supply Chain Logistics: How Blood Centers Participate in Collection, Storage, and Delivery of Cell Therapies
Manufacturing
Best Practices in Supply Chain Logistics: How Blood Centers Participate in Collection, Storage, and Delivery of Cell Therapies
Best Practices in Supply Chain Logistics: How Blood Centers Participate in Collection, Storage, and Delivery of Cell Therapies
Sep 12, 2014
byBPI Staff
Cell Therapy Commercialization Through Automated Processing logo in a gray background | Cell Therapy Commercialization Through Automated Processing
Manufacturing
Cell Therapy Commercialization Through Automated Processing
Cell Therapy Commercialization Through Automated Processing
Sep 12, 2014
byBPI Staff
Roundtable: Advances in Novel, and Single-Use Technologies in Protein Purification — the Future of Chromatography logo in a gray background | Roundtable: Advances in Novel, and Single-Use Technologies in Protein Purification — the Future of Chromatography
Manufacturing
Roundtable: Advances in Novel, and Single-Use Technologies in Protein Purification — the Future of Chromatography
Roundtable: Advances in Novel, and Single-Use Technologies in Protein Purification — the Future of Chromatography
Sep 12, 2014
byBPI Staff
Implementation and Use of Single-Use Products: A CMO’s Perspective logo in a gray background | Implementation and Use of Single-Use Products: A CMO’s Perspective
Manufacturing
Implementation and Use of Single-Use Products: A CMO’s Perspective
Implementation and Use of Single-Use Products: A CMO’s Perspective
Sep 12, 2014
byBPI Staff
Regulatory Compliance in Single-Use BioManufacturing Facilities Requires a Collaborative Approach with your Supply Chain logo in a gray background | Regulatory Compliance in Single-Use BioManufacturing Facilities Requires a Collaborative Approach with your Supply Chain
Manufacturing
Regulatory Compliance in Single-Use BioManufacturing Facilities Requires a Collaborative Approach with your Supply Chain
Regulatory Compliance in Single-Use BioManufacturing Facilities Requires a Collaborative Approach with your Supply Chain
Sep 12, 2014
byBPI Contributor
Lowering Operational Costs with New Protein A Solutions for Single-Use Facilities logo in a gray background | Lowering Operational Costs with New Protein A Solutions for Single-Use Facilities
Manufacturing
Lowering Operational Costs with New Protein A Solutions for Single-Use Facilities
Lowering Operational Costs with New Protein A Solutions for Single-Use Facilities
Sep 12, 2014
byBPI Staff
Single-Use Development and Use of Single-Use Vials for Sterile Processing logo in a gray background | Single-Use Development and Use of Single-Use Vials for Sterile Processing
Manufacturing
Single-Use Development and Use of Single-Use Vials for Sterile Processing
Single-Use Development and Use of Single-Use Vials for Sterile Processing
Sep 12, 2014
byBPI Staff
How to Go into Commercial Scale with Single-Use logo in a gray background | How to Go into Commercial Scale with Single-Use
Manufacturing
How to Go into Commercial Scale with Single-Use
How to Go into Commercial Scale with Single-Use
Sep 12, 2014
byBPI Staff
The Future of Biomanufacturing: Faster, Better, Cheaper logo in a gray background | The Future of Biomanufacturing: Faster, Better, Cheaper
Manufacturing
The Future of Biomanufacturing: Faster, Better, Cheaper
The Future of Biomanufacturing: Faster, Better, Cheaper
Sep 12, 2014
byBPI Staff
Preparing for Preapproval Inspection (PAI): How toTransition Operations from Early Stage to Phase 3 and Commercial Production logo in a gray background | Preparing for Preapproval Inspection (PAI): How toTransition Operations from Early Stage to Phase 3 and Commercial Production
Manufacturing
Preparing for Preapproval Inspection (PAI): How toTransition Operations from Early Stage to Phase 3 and Commercial Production
Preparing for Preapproval Inspection (PAI): How toTransition Operations from Early Stage to Phase 3 and Commercial Production
Sep 12, 2014
byBPI Staff
Product Development Partnership: AERAS as a Model logo in a gray background | Product Development Partnership: AERAS as a Model
Manufacturing
Product Development Partnership: AERAS as a Model
Product Development Partnership: AERAS as a Model
Sep 12, 2014
byBPI Staff
Developing a Robust and Scalable CGMP Protein Manufacture Process logo in a gray background | Developing a Robust and Scalable CGMP Protein Manufacture Process
Manufacturing
Developing a Robust and Scalable CGMP Protein Manufacture Process
Developing a Robust and Scalable CGMP Protein Manufacture Process
Sep 12, 2014
byBPI Staff
The Future of Aseptic Filling: Automated Filling Robots Coming to a Clean Room Near You logo in a gray background | The Future of Aseptic Filling: Automated Filling Robots Coming to a Clean Room Near You
Manufacturing
The Future of Aseptic Filling: Automated Filling Robots Coming to a Clean Room Near You
The Future of Aseptic Filling: Automated Filling Robots Coming to a Clean Room Near You
Sep 12, 2014
byBPI Staff
CMO/CDMOs: How Technologies Are Changing Outsourcing Strategies, Services Offered, and Risks Taken logo in a gray background | CMO/CDMOs: How Technologies Are Changing Outsourcing Strategies, Services Offered, and Risks Taken
Manufacturing
CMO/CDMOs: How Technologies Are Changing Outsourcing Strategies, Services Offered, and Risks Taken
CMO/CDMOs: How Technologies Are Changing Outsourcing Strategies, Services Offered, and Risks Taken
Sep 12, 2014
byBPI Staff
The Client Experience: The Key to a CDMO’s Sustainable Future logo in a gray background | The Client Experience: The Key to a CDMO’s Sustainable Future
Manufacturing
The Client Experience: The Key to a CDMO’s Sustainable Future
The Client Experience: The Key to a CDMO’s Sustainable Future
Sep 12, 2014
byBPI Staff
GMP Considerations for Bioprocess Design: A CMO Perspective logo in a gray background | GMP Considerations for Bioprocess Design: A CMO Perspective
Manufacturing
GMP Considerations for Bioprocess Design: A CMO Perspective
GMP Considerations for Bioprocess Design: A CMO Perspective
Sep 12, 2014
byBPI Staff

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Light Boxes and Beyond: Maximizing Confidence in Clone Selection Using the Beacon Optofluidic System
Register Now: Light Boxes and Beyond: Maximizing Confidence in Clone Selection Using the Beacon Optofluidic System
Insider News
See all
Mar 18 - Mar 21, 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.
Learn More

Innovative Technology

Thermo Fisher Scientific peptones white paper
Sponsored Content
The Value of Peptones for Enhancing Biopharmaceutical Productivity
The Value of Peptones for Enhancing Biopharmaceutical Productivity

Jan 27, 2025

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe